Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.61B |
| 2 |
Microsoft
MSFT
|
+$1.17B |
| 3 |
Broadcom
AVGO
|
+$366M |
| 4 |
Merck
MRK
|
+$343M |
| 5 |
Meta Platforms (Facebook)
META
|
+$260M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$609M |
| 2 |
CMA
Comerica
CMA
|
+$512M |
| 3 |
CADE
Cadence Bank
CADE
|
+$422M |
| 4 |
Johnson & Johnson
JNJ
|
+$331M |
| 5 |
Western Digital
WDC
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.81% |
| 2 | Financials | 17.07% |
| 3 | Industrials | 12.55% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Healthcare | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1851
OR Royalties Inc
OR
$6.36B
| $25.8M | 0.01% |
677,822
+141,904
| +26% | +$5.83M |
2017 Q4
33 quarters
|
|
|
SHOE
1852
Shoe Station Group
SHOE
$345M
| $25.7M | 0.01% |
1,651,332
+44,759
| +3% | +$850K |
2013 Q2
51 quarters
|
|
1853
Vitesse Energy
VTS
$706M
| $25.6M | 0.01% |
1,412,165
-8,532
| -0.6% | -$172K |
2023 Q1
12 quarters
|
|
1854
BioCryst Pharmaceuticals
BCRX
$2.07B
| $25.6M | 0.01% |
2,690,651
+1,461,799
| +119% | +$11.4M |
2025 Q4
1 quarter
|
|
1855
United Microelectronic
UMC
$63.2B
| $25.6M | 0.01% |
2,849,737
+333,011
| +13% | +$3.25M |
2013 Q2
51 quarters
|
|
1856
Vaalco Energy
EGY
$610M
| $25.5M | 0.01% |
4,028,909
+389,058
| +11% | +$1.96M |
2018 Q2
31 quarters
|
|
1857
Castle Biosciences
CSTL
$1.08B
| $25.5M | 0.01% |
1,039,761
-104,038
| -9% | -$3.41M |
2021 Q3
18 quarters
|
|
|
GTY
1858
Getty Realty Corp
GTY
$1.72B
| $25.5M | 0.01% |
802,609
+39,683
| +5% | +$1.24M |
2013 Q2
51 quarters
|
|
1859
Waterstone Financial
WSBF
$351M
| $25.5M | 0.01% |
1,413,502
-1,647
| -0.1% | -$29.3K |
2013 Q2
51 quarters
|
|
1860
CareDx
CDNA
$3.43B
| $25.4M | 0.01% |
1,461,914
+151,934
| +12% | +$2.88M |
2019 Q3
26 quarters
|
|
|
EFXT
1861
Enerflex
EFXT
$3.11B
| $25.3M | 0.01% |
1,208,011
+303,398
| +34% | +$5.79M |
2024 Q2
7 quarters
|
|
1862
Disc Medicine
IRON
$2.44B
| $25.2M | 0.01% |
394,447
+170,872
| +76% | +$11.9M |
2024 Q3
6 quarters
|
|
1863
Mistras Group
MG
$657M
| $25.2M | 0.01% |
1,703,681
+35,835
| +2% | +$517K |
2013 Q2
51 quarters
|
|
|
LTC
1864
LTC Properties
LTC
$2.3B
| $25.2M | 0.01% |
676,970
+20,864
| +3% | +$785K |
2013 Q2
51 quarters
|
|
1865
Malibu Boats
MBUU
$449M
| $25.1M | 0.01% |
967,068
+52,635
| +6% | +$1.57M |
2015 Q3
42 quarters
|
|
1866
PACS Group
PACS
$6.5B
| $25.1M | 0.01% |
780,159
+614,250
| +370% | +$22.6M |
2025 Q4
1 quarter
|
|
1867
Marcus Corp
MCS
$836M
| $24.9M | 0.01% |
1,451,780
-17,543
| -1% | -$280K |
2013 Q2
51 quarters
|
|
1868
Pennant Group
PNTG
$1.35B
| $24.9M | 0.01% |
815,660
+11,943
| +1% | +$369K |
2019 Q4
25 quarters
|
|
1869
FRP Holdings
FRPH
$393M
| $24.9M | 0.01% |
1,136,088
-891
| -0.1% | -$20.7K |
2013 Q2
51 quarters
|
|
1870
Nomura Holdings
NMR
$28.5B
| $24.9M | 0.01% |
3,150,585
-17,183
| -0.5% | -$148K |
2013 Q2
51 quarters
|
|
1871
John B. Sanfilippo & Son
JBSS
$779M
| $24.8M | 0.01% |
312,802
+12,056
| +4% | +$928K |
2013 Q2
51 quarters
|
|
1872
Stellantis
STLA
$13.6B
| $24.8M | 0.01% |
3,501,139
+574,048
| +20% | +$4.81M |
2014 Q4
45 quarters
|
|
1873
First Advantage
FA
$3.15B
| $24.7M | 0.01% |
2,099,921
-96,296
| -4% | -$1.18M |
2022 Q3
14 quarters
|
|
1874
Distribution Solutions Group
DSGR
$1.62B
| $24.6M | 0.01% |
937,151
+26,595
| +3% | +$744K |
2013 Q2
51 quarters
|
|
1875
Warner Music
WMG
$14.2B
| $24.6M | 0.01% |
963,167
-1,555
| -0.2% | -$44.1K |
2020 Q3
22 quarters
|
|
Similar funds
Dimensional Fund Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Dimensional Fund Advisors held 3,312 positions worth $481B, up 0.98% from $477B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q1 2026 filing shows 72 new, 1,935 increased, 1,135 reduced and 97 closed positions. Its largest new stake was Versant Media Group: 1,127,961 shares worth $41.7M. The largest sale was AstraZeneca, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2026 buy was Versant Media Group: 1,127,961 shares worth $41.7M.
- Dimensional Fund Advisors added most to Amazon in Q1 2026, an estimated $1.61B increase.
- Dimensional Fund Advisors's biggest Q1 2026 reduction was Johnson & Johnson, cutting an estimated $331M.
- Dimensional Fund Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $609M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $481B portfolio in Q1 2026.
- Dimensional Fund Advisors opened 72 new positions and closed 97 in Q1 2026.
- Dimensional Fund Advisors's portfolio value rose 0.98% quarter-over-quarter to $481B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.